The vaccine is expected to remain available for anyone who is at least 65 or who has a medical condition, leaving many Americans ineligible. Here's what we know.

The Trump administration released a 72-page report Thursday outlining its take on what's driving "a chronic disease crisis" ...

The FDA is implementing stricter guidance for the approval of COVID-19 vaccines, according to a paper published in The New England Journal of Medicine.

The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.

The travelers with cases linked to the NB.1.8.1 variant have been arriving at airports in California, Washington state, ...

Secretary Kennedy's appointment led to fears that vaccine availability would be curtailed. Those fears are now being realized.

Over the last several days, the safety and efficacy of messenger RNA, or mRNA, vaccines have come under intense scrutiny. On Tuesday, the U.S. Food and Drug Administration announced plans to limit ...

It may not be the mythical fountain of youth, but the strength of the body's immune system, or immune resilience, could hold ...

This week, two new leaders at the US Food and Drug Administration announced plans to limit access to covid vaccines, arguing ...

If I am unable to access a vaccine in the future and get a nasty case of COVID, I'll know where to point the finger and so will millions of others.

The United States is tightening its approval standards for COVID-19 boosters, a shift that has prompted growing concern in ...

After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...